BBLG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Bone Biologics Corp (BBLG) is not a good buy for a beginner, long-term investor at the moment. The technical indicators are neutral to bearish, financial performance is significantly weak, and there are no positive catalysts or trading signals to suggest a strong entry point. The stock's trend suggests potential short-term declines, making it unsuitable for an impatient investor unwilling to wait for better conditions.
The MACD is slightly positive and expanding, indicating mild bullish momentum. However, the RSI is neutral at 50.232, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 1.23, with resistance at 1.314 and support at 1.146. Overall, the technical indicators are mixed to bearish.
NULL identified. No recent news, no significant hedge fund or insider activity, and no congress trading data.
The stock has a 60% chance of declining by -0.37% in the next day, -3.26% in the next week, and -6.68% in the next month. Financial performance is weak, with significant YoY declines in net income (-55.01%) and EPS (-89.67%).
In Q4 2025, revenue remained at 0 with no growth. Net income dropped to -684,643, down -55.01% YoY. EPS fell to -0.38, down -89.67% YoY. Gross margin remained at 0 with no growth. The company is experiencing significant financial challenges.
No analyst ratings or price target changes available.
